This Article is From Mar 31, 2021

Brazil Says "No" To Covaxin, Bharat Biotech Explains

According to reports, a Brazilian government gazette had said that Covaxin had been rejected "considering the non-compliance with the requirements of Good Manufacturing Practices for Medicines''.

Advertisement
India News Reported by , Edited by

Bharat Biotech says around 40 countries have expressed interest in Covaxin (File)

Highlights

  • Brazil's health regulator has denied permission to import Covaxin
  • Reports say the rejection is over non-compliance of some requirements
  • The requirements will be fulfilled, Bharat Biotech has told NDTV
New Delhi:

Brazil's health regulator has denied permission to import Covaxin, the Covid vaccine produced by indigenous firm Bharat Biotech. Twenty million doses of the vaccine has been ordered by Brazil, the nation hit worst by Covid after the United States.

According to reports, a Brazilian government gazette had said that Covaxin had been rejected "considering the non-compliance with the requirements of Good Manufacturing Practices for Medicines''.

In its response, Bharat Biotech has told NDTV: ''The requirements pointed out during inspection will be fulfilled, the timelines for fulfilment is under discussion with the Brazil NRA and will be resolved soon.''

Covaxin, produced by Bharat Biotech in collaboration with the Indian Council for Medical Research, was approved for emergency use by the national drug regulator in January. The vaccine was expected to be used only in the "clinical trial mode".

Earlier this month, it was taken off clinical trial mode after the authorities said vaccine has showed an interim efficacy of 81 per cent in the Phase 3 clinical trials in India.  

Advertisement

Bharat Biotech said the vaccine is effective against the UK variant of the virus. The government has said the need to change the composition of Covaxin has not been felt yet in view of its efficacy against the mutant variants.

Several other nations, including Iran, Nepal, Mauritius, Paraguay and Zimbabwe have approved and received Covaxin for emergency use. Bharat Biotech had also applied for clearance in Brazil, Thailand and the Philippines. Bharat Biotech says around 40 countries have expressed interest in Covaxin.

Advertisement

Under the 'Vaccine Maitri' initiative, India has been providing coronavirus vaccines to more than 70  nations including Maldives, Bhutan, Bangladesh, Nepal, Sri Lanka, Myanmar, Mauritius, Seychelles and the Gulf nations.

Advertisement